To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with JavaScript enabled.
This website is not optimized for your browser, as configured.
Experiences

Tweetfest 2018: A Week of Collaboration and Learning

Tweetfest 2018 A Week of Collaboration and Learning Feature Image

Every May the Lilly Trials team looks forward to the #WhyWeDoResearch Tweetfest as an opportunity to collaborate with folks from around the globe who are involved in clinical research—from patients and caregivers to researchers and site staff. The week-long event includes two to three tweet chats each day, all focused on different topics and hosted by a variety of individuals and organizations (we hosted a chat on caregiving last year). The chats are full of meaningful conversation, insights and ideas on the current state of clinical research and future opportunities for improvement (here's an example from @VickyLShepherd of the types of insights that can be gained from #whywedoresearch chats.

Take a look at the numbers from this year's Tweetfest*, which was held during the week of May 14, and included participants from 10 different countries:

Tweetfest 2018 Symplur Stats

*There was another #WhyWeDoResearch event unrelated to Tweetfest during this time period, which accounted for a portion of the impressions, tweets, participants, etc. captured above.

While many interesting and important themes emerged from the Tweetfest discussions, we're highlighting just a few of our favorites below.

1. Health Literacy: A Multifaceted Concept
We know that health literacy skills help people to feel empowered as patients, especially when it comes to asking about and understanding clinical trial opportunities. While the definition of health literacy may sound straightforward, it can actually be nuanced and have multiple components.

Consider the idea of "health experience literacy"—extending the definition of health literacy to include an understanding for the actions that patients may potentially need or want to take as part of their health care experience.

Or "research literacy"—honing in on clinical research-specific aspects of health care that are important for patients and caregivers to understand in order to make informed decisions about participation.

A final health literacy take-away focuses on the importance of the words used to talk about clinical research and begs the question: How can we as a community shift the way we speak about clinical trials to better convey the value of research to potential participants and their caregivers?

2. Social Platforms: Many people turn to social media and online communities to learn about clinical research, but each channel provides unique value to different people.

From the explosion of social media platforms and online patient communities emerged new and effective methods of not only learning about clinical research, but making connections with others who are going through similar health experiences.

While some Tweetfest participants cited Facebook as their go-to social media channel...

...others turn to Twitter as a resource of health information and support.

We are fans of social media, of course, but the chat also uncovered some unintended consequences of social media content.

3. The #WhyWeDoResearch Campaign: A fantastic way to bring people from across the clinical research community together to share ideas and discuss potential ways to improve clinical research.

One of the chats during this year's Tweetfest focused on the #WhyWeDoResearch event itself. During the chat participants shared their feedback on Tweetfest—what they liked, potential improvements, and, best of all, appreciation for one another. Here are a few highlights:

Thank you to Hazel for hosting a wonderful Tweetfest event, and to each and every participant. We are always thankful for the opportunity to hear your insights and perspective on clinical research.

Blog post originally appeared on LillyPad.

Tags: Digital Health, Why We Do Research,

Recent Articles

COVID-19TrialsUnderway FeatureImage 22June2020

Lilly’s COVID-19 Clinical Trials are Underway

LTGBlogAuthors LillyGuestAuthorIcon 20July2018
Lilly Guest Author
June 22nd, 20206 minute read

Lilly has worked quickly to launch studies of potential COVID-19 antibody treatments. Find out what makes antibodies an intriguing scientific and medical option.

COVID-19ResearchTypes FeatureImage1 19May2020

Types of Clinical Research for COVID-19

Leigh Anne Naas Headshot
Leigh Anne Naas
June 3rd, 20206 minute read

As the world works to quickly learn about COVID-19, a mix of research studies is underway. This guide explains the different types of COVID-19 studies and what researchers hope to learn from them.

AStoryofResearchVolunteers FeatureImage 6May2020-01

Meet Four Research Volunteers

Leigh Anne Naas Headshot
Leigh Anne Naas
May 13th, 20201 minute read

Over 2 million brave people take part in clinical trials every year, testing new treatments that may make life better. Meet four of those people.

InnovationInClinicalTrials TweetChatBlog 14May2020-01

Tweet Chat: Uncovering Innovation in Clinical Trials

Leigh Anne Naas Headshot
Leigh Anne Naas
May 27th, 20203 minute read

On International Clinical Trials Day, we hosted a tweet chat to generate conversation on #ClinicalTrialInnovation. If you didn’t have a chance to attend, we’ve broken down the key takeaways here.

A De-centralized Response Featured Image

Clinical Trials: A De-Centralized Response

BlogAuthor Don2 3Dec2019
Don Harder
May 4th, 20203 minute read

The quick adoption and scaling of decentralized trials will be one of the positive outcomes of having to look at the world of clinical trials in a different way. Learn more about the shift.